Filter by

Keywords

Congress

Year

abstract book

Access here all Abstracts accepted for oral and e-poster presentation at PCR congresses. You can browse by theme, topic or if you know what you are looking for, by author, title using the free search

Lond19A-OP001
30-day outcomes from a global early feasibility study to assess the safety and effectiveness of a novel transfemoral TAVR system for the treatment of patients with symptomatic severe aortic regurgitation
VAHL T. (1), LEON M. (1), BALDUS S. (2), THOURANI V. (3), TREEDE H. (4), MAKKAR R. (5), KODALI S. (1), VAN MIEGHEM N. (6), RUDOLPH T. (7), WALTHER T. (8)
(1) Columbia University, NY UNITED STATES
(2) Uniklinik Köln, Cologne GERMANY
(3) MedStar Washington Hospital Center, DC UNITED STATES
(4) UKB University of Bonn, Bonn GERMANY
(5) Cedars-Sinai Medical Center, CA UNITED STATES
(6) Erasmus Universiteit Rotterdam, Rotterdam NETHERLANDS
(7) HDZ NRW, Bad Oeynhausen GERMANY
(8) Universitätsklinikum Frankfurt, Frankfurt GERMANY

+

Lond19A-OP002
Propensity score matched analysis between TAVI and isolated surgical aortic valve implantation in young high-risk patients aged 75 years or less
MACH M. (1), SLAKOV U. (2), WALLMüLLER C. (3), KEIL C. (3), STRATIL P. (3), STROUHAL A. (3), ADLBRECHT C. (3), DELLE-KARTH G. (3), GRABENWöGER M. (2), SCHOBER A. (3)
(1) Medical University of Vienna, Department of Cardiac Surgery, Vienna AUSTRIA
(2) Hospital Hietzing, Department of Cardiothoracic and Vascular Surgery, Vienna AUSTRIA
(3) Hospital Hietzing, Department of Cardiology, Vienna AUSTRIA

+

Lond19A-OP004
A novel heart failure score predicts adverse outcome in patients undergoing TAVI
MACH M. (1), WINKLER B. (2), SCHOBER A. (3), STROUHAL A. (3), DELLE-KARTH G. (3), GRABENWöGER M. (2), ADLBRECHT C. (3)
(1) Medical University of Vienna, Department of Cardiac Surgery, Vienna AUSTRIA
(2) Hospital Hietzing, Department of Cardiothoracic and Vascular Surgery, Vienna AUSTRIA
(3) Hospital Hietzing, Department of Cardiology, Vienna AUSTRIA

+

Lond19A-OP005
The FIFA-trial: FItness-tracker assisted Frailty-Assessment before TAVI
MACH M. (1), WATZAL V. (2), WINKLER B. (2), STROUHAL A. (3), ADLBRECHT C. (3), DELLE-KARTH G. (3), GRABENWöGER M. (2)
(1) Medical University of Vienna, Department of Cardiac Surgery, Vienna AUSTRIA
(2) Hospital Hietzing, Department of Cardiothoracic and Vascular Surgery, Vienna AUSTRIA
(3) Hospital Hietzing, Department of Cardiology, Vienna AUSTRIA

+

Lond19A-OP006
Predictors of permanent pacemaker implantation after TAVI in patients with very large annuli with a self-expanding valve
JIMENEZ V. A. (1), JIMENEZ DIAZ V. A. (1), LOPEZ OTERO D. (2), CRUZ GONZALEZ I. (3), AMAT-SANTOS I. (4), RIVERO F. (5), GUTIERREZ IBAñEZ E. (6), MUñOZ GARCIA A. (7), VAQUERIZO B. (8), MORENO SAMOS J. C. (3), RODRIGUEZ-GABELLA T. (4), GONZALEZ SALDIVAR H. (6)
(1) Hospital Álvaro Cunqueiro, Vigo SPAIN
(2) Hospital Universitario de Santiago de Compostela, Santiago de Compostela SPAIN
(3) Hospital Clínico Universitario de Salamanca, Salamanca SPAIN
(4) Hospital Clínico Universitario de Valladolid, Valladolid SPAIN
(5) Hospital de La Princesa, Madrid SPAIN
(6) Gregorio Marañón Hospital, Madrid SPAIN
(7) Hospital Universitario Virgen de la Victoria, Málaga SPAIN
(8) Hospital del Mar, Barcelona SPAIN

+

Lond19A-OP007
Very early discharge after transfemoral TAVI in selected patients; is it safe?
CALABUIG A. (1), VICENS S. (1), MARTI G. (1), SERRA B. (1), OTAEGUI I. (1), DOMINGO E. (1), BELLERA N. (1), DIAZ M. (1), SUASNAVAR P. (1), GONZALEZ S. (1), GARCIA B. (1)
(1) Vall d'Hebron University Hospital, Barcelona SPAIN

+

Lond19A-OP008
The concept of futility in treating functional mitral regurgitation in real world
GAVAZZONI M. (1), ADAMO M. (2), ESTéVEZ LOUREIRO R. (3), POZZOLI A. (1), CURELLO S. (2), BENITO T. (3), PORTOLèS A. (4), MIZUKI M. (1), SCIANNA S. (1), ZUBER M. (1), TARAMASSO M. (1), MAISANO F. (1)
(1) Universitätsspital Zürich, Zürich SWITZERLAND
(2) Spedali Civili, Piazzale Spedali Civili, Brescia, Province of Brescia ITALY
(3) university hospital, León SPAIN
(4) Hospital Puerta De Hierro, Majadahonda SPAIN

+

Lond19A-OP009
Systematic cerebral protection during TAVI: a single-centre experience
PIVA T. (1), NICOLINI E. (1), MUCAJ A. (1), ALESSANDRO M. (1), MIRCO B. (1), ANDREA A. (1), MASSIMILIANO S. (1), ALESSANDRO A. (1), GABRIELE G. (1)
(1) Ospedali Riuniti, Province of Ancona ITALY

+

Lond19A-OP010
Clinical data, performance and safety of TAVI in very large annuli with a self-expandable valve
JIMENEZ V. A. (1), JIMENEZ V. (1), LOPEZ-OTERO D. (2), CRUZ-GONZALEZ I. (3), AMAT-SANTOS I. (4), RIVERO F. (5), GUTIERREZ IBAñEZ E. (6), MUñOZ GARCIA A. (7), VAQUERIZO B. (8), TRILLO NOUCHE R. (2), MORENO SAMOS J. C. (3), RODRIGUEZ-GABELLA T. (4)
(1) Álvaro Cunqueiro Hospital, Vigo SPAIN
(2) Hospital, Santiago de Compostela SPAIN
(3) Hospital Clínico Universitario de Salamanca, Salamanca SPAIN
(4) Hospital Clínico Universitario de Valladolid, Valladolid SPAIN
(5) Hospital de La Princesa, Madrid SPAIN
(6) Gregorio Marañón Hospital, Madrid SPAIN
(7) Hospital Universitario Virgen de la Victoria, Málaga SPAIN
(8) Hospital del Mar, Barcelona SPAIN

+

Lond19A-OP011
First mid-/long-term follow-up results in patients undergoing TAVR with the self-expandable Portico valve for severe aortic stenosis: a real-world prospective study
MAS-PEIRO S. (1), SEPPELT P. C. (1), DE ROSA R. (1), MURRAY M. I. (1), WALTHER T. (1), ZEIHER A. M. (1), FICHTLSCHERER S. (1), VASA-NICOTERA M. (1)
(1) University Hospital Frankfurt, Frankfurt am Main GERMANY

+

Lond19A-OP012
Long-term experience with mechanical aortic valve prostheses after one-third of a century
AREF T. (1), WIEDEMANN D. (1), ROSENHEK R. (1), HIESMAYR M. (1), KOCHER A. (1), ANDREAS M. (1)
(1) Medical University of Vienna, Vienna AUSTRIA

+

Lond19A-OP013
Assessment of right atrial deformation indices in patients with different scales of significant secondary tricuspid regurgitation
OKUTUCU S. (1), SIMSEK V. (1), AKSOY H. (1), BURSA N. (2), YETIS SAYIN B. (1), OTO A. (1)
(1) Memorial Ankara Hastanesi, Ankara TURKEY
(2) Hacettepe Üniversitesi Beytepe Kampüsü, Ankara TURKEY

+

Lond19A-OP014
A prospective multicentre study of the SAPIEN 3 Ultra system in intermediate-risk patients with severe aortic stenosis
PRENDERGAST B. (1), HORLICK E. (2), RODES-CABAU J. (3), MACCARTHY P. (4), VELIANOU J. (5), WOOD D. (6), HOVORKA T. (7), WEBB J. (8)
(1) Guy's and St Thomas' NHS Foundation Trust, London UNITED KINGDOM
(2) Toronto General Hospital, ON CANADA
(3) Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ), QC CANADA
(4) King's College Hospital NHS Foundation Trust, London UNITED KINGDOM
(5) Hamilton Health Sciences, McMaster University, Hamilton, ON, Hamilton CANADA
(6) St. Paul's Hospital, University of British Columbia, Vancouver, BC, Vancouver CANADA
(7) Edwards Lifesciences, Prague, Prague CZECH REPUBLIC
(8) St. Paul's Hospital, University of British Columbia, Vancouver CANADA

+

Lond19A-OP015
Five-year clinical outcomes after percutaneous edge-to-edge mitral valve repair: insights from the multicentre GRASP-IT registry
ADAMO M. (1), GRASSO C. (2), POPOLO RUBBIO A. (2), CAPODANNO D. (2), CRISTINA G. (3), FIORELLI F. (3), PETRONIO A. S. (3), BEDOGNI F. (4), CURELLO S. (1), TAMBURINO C. (2)
(1) Spedali Civili of Brescia , Brescia ITALY
(2) CAST Policlinico Vittorio Emanuele, Catania ITALY
(3) AUOP Piasana, Pisa ITALY
(4) IRCCS Policlinico San Donato, Milano ITALY

+

Lond19A-OP016
Neurological events from the Evolut low-risk study
TCHETCHE D. (1), POPMA J. (2), YAKUBOV S. (3), DEEB G. M. (4), GLEASON T. (5), KLEIMAN N. (6), WALTON A. (7), REARDON M. (6)
(1) Clinic Pasteur, Toulouse FRANCE
(2) Beth Israel Deaconess Medical Center (BIDMC), MA UNITED STATES
(3) Riverside Methodist Hospital, OH UNITED STATES
(4) University of Michigan, MI UNITED STATES
(5) University of Pittsburgh, PA UNITED STATES
(6) Methodist Debakey Heart and Vascular Center, TX UNITED STATES
(7) The Alfred Hospital, VIC AUSTRALIA

+

Lond19A-OP017
Valve-in-valve implantation using the ACURATE neo in degenerated aortic bioprostheses: an international multicentre analysis
TOGGWEILER S. (1), HOLZAMER A. (2), KIM W. K. (3), SATHANANTHAN J. (4), KELLER L. (5), BRINKERT M. (1), HILKER M. (2), NIETLISPACH F. (5), WEBB J. (4)
(1) Luzerner Kantonsspital, Lucerne SWITZERLAND
(2) Universitätsklinikum Regensburg, Regensburg GERMANY
(3) Bad Nauheimer Klinik, Bad Nauheim GERMANY
(4) St Pauls Hospital, BC CANADA
(5) Universitätsspital Zürich, Zürich SWITZERLAND

+

Lond19A-OP018
Assessment of long-term structural deterioration of transcatheter aortic bioprosthetic valves using the new European definition - A multicentre French study
SOKOLOFF A. (1), DURAND E. (2), URENA ALCAZAR M. (3), HIMBERT D. (3), IUNG B. (3), BLANCHARD D. (4), GILARD M. (5), CRIBER A. (2), LEFEVRE T. (6), ELTCHANINOFF H. (2)
(1) INSTITUT MUTUALISTE MONTSOURIS, PARIS FRANCE
(2) HOPITAL CHARLES NICOLLE CHU ROUEN, ROUEN FRANCE
(3) Bichat-Claude Bernard Hospital, Paris FRANCE
(4) CLINIQUE SAINT-GATIEN - TOURS, TOURS FRANCE
(5) CHRU BREST SITE HOPITAL MORVAN, BREST FRANCE
(6) Cardiovascular Institute Paris Sud (ICPS), Massy FRANCE

+

Lond19A-OP019
A set of pre-specified risk criteria facilitates appropriately timed discharge and sustained outcomes to one year after hospital discharge for patients having transfemoral TAVI based on the FAST TAVI trial
SPENCE M. (1), BAAN J. (2), MARTINELLI G. L. (3), MUIR D. F. (4), SAIA F. (5), BORTONE A. (6), DENSEM C. G. (7), VAN DER KLEY F. (8), VAN MOURIK M. S. (2), BRAMLAGE P. (9), BARBANTI M. (10)
(1) Royal Victoria Hospital, Belfast UNITED KINGDOM
(2) UMCA - Locatie AMC, Amsterdam NETHERLANDS
(3) Clinica San Gaudenzio, Province of Novara ITALY
(4) The James Cook University Hospital, Middlesbrough UNITED KINGDOM
(5) S Orsola Malpighi Pad 5, Metropolitan City of Bologna ITALY
(6) University of Bari Aldo Moro, Metropolitan City of Bari ITALY
(7) Papworth Trust, Cambridge UNITED KINGDOM
(8) Leiden University Medical Center (LUMC), Leiden NETHERLANDS
(9) Institute for Pharmacology and Preventive Medicine, Cloppenburg GERMANY
(10) Policlinico ?Vittorio Emanuele?, Province of Catania ITALY

+

Lond19A-OP021
Transcatheter treatment of bicuspid aortic valves with the Evolut platform: interim analysis from the BIVOLUT-X registry
TCHETCHE D. (1), DE BIASE C. (1), ZIVIELLO F. (2), HOVASSE T. (3), SONDERGAARD L. (4), TEIGER E. (5), TELES R. (6), DUMONTEIL N. (1), VAN MIEGHEM N. (2)
(1) CLINIQUE PASTEUR, TOULOUSE FRANCE
(2) Erasmus MC, Rotterdam NETHERLANDS
(3) HOPITAL PRIVE JACQUES CARTIER, MASSY FRANCE
(4) Rigshospitalet, Copenhagen Municipality DENMARK
(5) HU HENRI MONDOR SITE HENRI MONDOR APHP, CRETEIL FRANCE
(6) Santa Cruz Hospital, Lisbon PORTUGAL

+

Lond19A-OP022
Adoption of newer MDCT measurements can lower pacemaker rates after TAVR in a community hospital setting
CHRYSANT G. (1), SPARLING J. (1), BEAGLES J. (1), CLARK C. (1), ELKINS C. (1)
(1) INTEGRIS Baptist Medical Center, OK UNITED STATES

+

Lond19A-OP023
Clinical and echocardiographic impact of under and over expansion of SAPIEN 3 transcatheter heart valves to tailor to aortic annular sizes
ADUSUMALLI S. (1), LAU K. (1), ROPER D. (1), SAVAGE M. (1), RAFFEL C. (1), SCALIA G. M. (1), POON K. (1)
(1) The Prince Charles Hospital, QLD AUSTRALIA

+

Lond19A-OP024
Novel anatomic predictors of new conduction disturbances after Edwards SAPIEN 3 and Evolut TAVI
ZAID S. (1), AHMAD H. (1), KHAN A. (2), KAPLE R. (3), UNDEMIR C. (1), LANSMAN S. (1), DANGAS G. (2), SHARMA S. (2), KINI A. (2), TANG G. (2)
(1) Westchester Medical Center, NY UNITED STATES
(2) Mount Sinai Health System, NY UNITED STATES
(3) Yale School of Medicine, CT UNITED STATES

+

Lond19A-OP025
Outcomes with initial use of cerebral embolic protection in all comers at a single TAVI site
STRIPE B. (1), SOUTHARD J. (1), WONG G. (1)
(1) UC Davis Medical Center, CA UNITED STATES

+

Lond19A-OP026
Early tricuspid annular reshaping with the MitraClip XTR device used to treat severe functional tricuspid regurgitation
ANDREAS M. (1), RUSSO M. (1), ZILBERSZAC R. (1), WERNER P. (1), SCHERZER S. (1), SCHNEIDER M. (1), TARAMASSO M. (2), ZUBER M. (2), MASCHERBAUER J. (1)
(1) Medizinische Universität Wien, Vienna AUSTRIA
(2) Universitätsspital Zürich, Zürich SWITZERLAND

+

Lond19A-OP027
The importance of prosthetic valve coaxiality in the occurrence of new conduction disturbances after TAVI: a retrospective CT-based study
OU Y. (1), ZHAO Z. (1), YAO Y. (1), HE J. (1), WANG Z. (1), LI Y. (1), LIAO Y. (1), PENG Y. (1), FENG Y. (1), CHEN M. (1)
(1) West China Medical School, West China Hospital, Sichuan University, Sichuan CHINA

+

Lond19A-OP028
One-year outcomes of the TRI-REPAIR study assessing Cardioband tricuspid valve reconstruction system for patients with functional tricuspid regurgitation
NICKENIG G. (1), VON BARDELEBEN R. S. (2), SCHAEFER U. (3), KUCK K. H. (4), VAHANIAN A. (5), JULIARD J. M. (5), LATIB A. (6), BALDUS S. (7), MAISANO F. (8), HAUSLEITER J. (9)
(1) University Hospital Bonn, Bonn GERMANY
(2) University Medical Center Mainz, Mainz GERMANY
(3) University Heart Center Hamburg GmbH, Hamburg GERMANY
(4) St. George Hospital, Hamburg GERMANY
(5) Bichat Hospital, Paris FRANCE
(6) San Raffaele Institute, Milan ITALY
(7) University Hospital Cologne, Cologne GERMANY
(8) University Hospital of Zürich, Zürich SWITZERLAND
(9) Ludwig-Maximilians University Hospital, Munich GERMANY

+

Lond19A-OP029
One-year outcomes from the multicentre, prospective study with the novel PASCAL transcatheter valve repair system for patients with mitral regurgitation in the CLASP study
NG M. (1), LIM S. (2), KAR S. (3), WALTERS D. (4), WEBB J. (5), FAM N. (6), RINALDI M. (7), KIPPERMAN R. (8), LATIB A. (9), COHEN G. (10), SMITH R. (11)
(1) Royal Prince Alfred Hospital, NSW AUSTRALIA
(2) University of Virginia Health System Hospital, Charlottesville UNITED STATES
(3) Cedars-Sinai Medical Center, CA UNITED STATES
(4) The Prince Charles Hospital, QLD AUSTRALIA
(5) St. Paul's Hospital, BC CANADA
(6) St. Michael's Hospital, ON CANADA
(7) Sanger Heart & Vascular Institute, Charlotte UNITED STATES
(8) Atlantic Health System Morristown Medical Center, Morristown UNITED STATES
(9) San Raffaele Hospital, Metropolitan City of Milan ITALY
(10) Sunnybrook Health Sciences Centre, ON CANADA
(11) The Heart Hospital Baylor Plano, Plano UNITED STATES

+

Lond19A-OP030
RESPOND post-market study: three-year outcomes following TAVI with a repositionable and fully retrievable aortic valve
VAN MIEGHEM N. (1), WöHRLE J. (2), BLEIZIFFER S. (3), BLACKMAN D. J. (4), HILDICK-SMITH D. (5), ABDEL-WAHAB M. (6), LINKE A. (7), INCE H. (8), GERCKENS U. (8), MEREDITH I. T. (9), FALK V. (10)
(1) Erasmus MC, Rotterdam NETHERLANDS
(2) Medical Campus Lake Constance, Friedrichshafen GERMANY
(3) Ruhr-University Bochum, Bad Oeynhausen GERMANY
(4) Leeds General Infirmary, Leeds UNITED KINGDOM
(5) Brighton and Sussex University Hospitals, Brighton UNITED KINGDOM
(6) University of Leipzig, Leipzig GERMANY
(7) Herzzentrum Dresden Universitätsklinik an der Technischen Universität Dresden, Dresden GERMANY
(8) University Hospital of Rostock, Rostock GERMANY
(9) Boston Scientific Corporation, Marlborough UNITED STATES
(10) Deutsches Herzzentrum Berlin, Berlin GERMANY

+

Lond19A-OP031
Incidence and outcomes of patient-prosthesis mismatch following self-expanding TAVI: an analysis from the STS/ACC TVT registry
TANG G. (1), BAPAT V. (2), ADAMS D. (1), KODALI S. (2), RAMLAWI B. (3), GADA H. (4), FORREST J. (5), KAPLE R. (5), REARDON M. (6)
(1) Columbia University, NY UNITED STATES
(2) Mount Sinai Medical Center, NY UNITED STATES
(3) Valley Health Systems, VA UNITED STATES
(4) University of Pittsburgh Medical Center Pinnacle, Wormsleyburg, Pennsylvania UNITED STATES
(5) Yale New Haven Hospital, CT UNITED STATES
(6) Methodist Debakey Heart and Vascular Center, TX UNITED STATES

+

Lond19A-OP032
Feasibility of repeat TAVI after SAPIEN 3 TAVI (TAV-in-TAV): a pilot angiographic study
TANG G. (1), GUPTA E. (1), ZAID S. (2), AHMAD H. (2), KHAN A. (1), GOLDBERG J. (2), UNDEMIR C. (2), DANGAS G. (1), SHARMA S. (1), KINI A. (1)
(1) Mount Sinai Medical Center, NY UNITED STATES
(2) Westchester Medical Center, NY UNITED STATES

+

Lond19A-OP033
Impact of initial Evolut TAVR deployment orientation on final valve orientation and coronary re-access: a pilot study
TANG G. (1), ZAID S. (2), GUPTA E. (1), AHMAD H. (2), KHAN A. (1), GOLDBERG J. (2), UNDEMIR C. (2), DANGAS G. (1), SHARMA S. (1), KINI A. (1)
(1) Mount Sinai Medical Center, NY UNITED STATES
(2) Westchester Medical Center, NY UNITED STATES

+

Lond19A-OP034
Safety and efficacy of transaxillary TAVI with a newer-generation balloon-expandable valve
ZHAN Y. (1), TOOMEY N. (1), KAWABORI M. (1), RASTEGAR H. (1), WEINTRAUB A. (1), CHEN F. (1)
(1) Tufts Medical Center, MA UNITED STATES

+

Lond19A-OP035
TAVI in cardiogenic shock: TAVI-shock registry results
FRACCARO C. (1), CAMPANTE TELES R. (2), TCHéTCHé D. (3), SAIA F. (4), BEDOGNI F. (5), MONTORFANO M. (6), FIORINA C. (7), MEUCCI F. (8), DE BENEDICTIS M. (9), LEONZI O. (10), BARBIERATO M. (11), DUMONTEIL N. (3), STOLCOVA M. (8), MAFFEO D. (10), COMPAGNONE M. (4), BRITO J. (2), CHIEFFO A. (6), TARANTINI G. (1)
(1) University of Padua, Province of Padua ITALY
(2) Santa Cruz Hospital, Carnaxide PORTUGAL
(3) Clinique Pasteur, Toulouse FRANCE
(4) Policlinico Sant'Orsola-Malpighi, Metropolitan City of Bologna ITALY
(5) IRCCS Policlinico San Donato, Metropolitan City of Milan ITALY
(6) San Raffaele Hospital, Metropolitan City of Milan ITALY
(7) Spedali Civili, Piazzale Spedali Civili, Brescia, Province of Brescia ITALY
(8) Careggi, Metropolitan City of Florence ITALY
(9) Ospedale Mauriziano Torino, Metropolitan City of Turin ITALY
(10) Poliambulanza Institute Hospital Foundation, Province of Brescia ITALY
(11) Azienda ULSS3 Serenissima, Metropolitan City of Venice ITALY

+

Lond19A-OP036
The Portico transcatheter aortic valve delivered via alternative access: one-year results from the Portico ALT study
VAN WELY M. (1), BRUSCHI G. (2), BEDOGNI F. (3), THIELE H. (4), JEGER R. V. (5), SOENDERGAARD L. (6), KEMPFERT J. (7), SCHLENSAK C. (8), LINKE A. (9)
(1) Radboud University Medical Center, Nijmegen NETHERLANDS
(2) Ospedale Niguarda Ca' Granda, Metropolitan City of Milan ITALY
(3) Policlinico san donato, Metropolitan City of Milan ITALY
(4) Herzzentrum Leipzig, Leipzig GERMANY
(5) Basel University, Basel SWITZERLAND
(6) Rigshospitalet, Copenhagen Municipality DENMARK
(7) Deutsches Herzzentrum Berlin, Berlin GERMANY
(8) Tübingen University Hospital, Tübingen GERMANY
(9) Herzzentrum Dresden Universitätsklinik an der Technischen Universität Dresden, Dresden GERMANY

+

Lond19A-OP037
Changes in invasive haemodynamics following MitraClip therapy according to LVEF
KUWATA S. (1), IZUMO M. (1), KAMIJIMA R. (1), NISHIKAWA H. (1), SATO Y. (1), KAIHARA T. (1), KOGA M. (1), WATANABE M. (1), OKUYAMA K. (1), YONEYAMA K. (1), SAKAMOTO M. (1), NAWATA K. (1), TAKESHI M. (1), TANABE Y. (1), HIGUMA T. (1), ISHIBASHI Y. (1), AKASHI Y. (1)
(1) St. Marianna University School of Medicine, Kanagawa JAPAN

+

Lond19A-OP038
Assessment of coronary artery obstruction risk during TAVR utilising 3D-printing
GURVITCH R. (1), RUSSO J. (1), YUEN T. (1)
(1) The Royal Melbourne Hospital, VIC AUSTRALIA

+

Lond19A-OP040
TAVR for failed surgical aortic bioprostheses using a self-expanding device: two-year outcomes from the prospective VIVA post-market study
KORNOWSKI R. (1), TCHETCHE D. (2), VERHOYE J. P. (3), CHEVALIER B. (4)
(1) Rabin Medical Center, Petah Tikva ISRAEL
(2) CLINIQUE PASTEUR, TOULOUSE FRANCE
(3) CHU Rennes, Rennes FRANCE
(4) HOPITAL PRIVE JACQUES CARTIER, MASSY FRANCE

+

Lond19A-OP041
Initial deployment orientation of ACURATE neo transcatheter heart valve and final commissural alignment: a pilot study on optimising post-procedural coronary access
FUCHS A. (1), GUPTA E. (2), ZAID S. (1), KOFOED K. (1), SONDERGAARD L. (1), DE BACKER O. (1), TANG G. (2)
(1) Rigshospitalet, Copenhagen Municipality DENMARK
(2) Mount Sinai Medical Center, NY UNITED STATES

+

Lond19A-OP042
Prognostic value of diastolic flow reversal on clinical outcomes after TAVR: an intraprocedural transoesophageal echocardiography study
OTA M. (1), IZUMO M. (2), MOCHIZUKI Y. (1), AKASHI Y. (2), TOSHIRO S. (1), SATO Y. (2), MIKA W. (2), KAMIJIMA R. (2), TANABE Y. (2), HARADA T. (2), OKUYAMA K. (2)
(1) Showa University Hospital, Tokyo JAPAN
(2) St. Marianna Medical University Hospital, Kanagawa JAPAN

+

Lond19A-OP043
Predictors and safety of next-day discharge after minimalistic transfemoral aortic valve implantation in an all-comer population
COSTA G. (1), BARBANTI M. (1), PICCI A. (1), TODARO D. (1), SGROI C. (1), TAMBURINO C. (1)
(1) AOU Policlinico G. Rodolico-Vittorio Emanuele, Centro Alte Specialità e Trapianti, Catania ITALY

+

Lond19A-OP044
Pacemaker dependency after TAVI: incidence, predictors and long-term outcomes
COSTA G. (1), ZAPPULLA P. (1), BARBANTI M. (1), CIRASA A. (1), TODARO D. (1), PICCI A. (1), RAPISARDA G. (1), SGROI C. (1), TAMBURINO C. (1), CALVI V. (1)
(1) AOU Policlinico G. Rodolico-Vittorio Emanuele, Centro Alte Specialità e Trapianti, Catania ITALY

+

Lond19A-OP135
Bicaval valved stent implantation in patients with severe functional tricuspid regurgitation
WINKEL M. (1), GRäNI C. (1), WUSTMANN K. (1), PILGRIM T. (1), MOSCHOVITIS A. (1), BRUGGER N. (1), BILLINGER M. (1), WINDECKER S. (1), PRAZ F. (1)
(1) University of Bern, Bern SWITZERLAND

+

Lond19A-OP136
Safety outcomes from the PORTICO IDE FlexNav Delivery System study of 100 high and extreme risk patients
FONTANA G. (1), CHEHAB B. (2), YONG G. (3), GARRETT H. E. (4), GROH M. (5), BEDOGNI F. (6), MAKKAR R. (7)
(1) Los Robles Regional Medical Center, CA, UNITED STATES
(2) Cardiovascular Research Institute of Kansas, KS, UNITED STATES
(3) Fiona Stanley Hospital, WA, AUSTRALIA
(4) Baptist Memorial Hospital Memphis, TN, UNITED STATES
(5) Mission Health and Hospitals, NC, UNITED STATES
(6) IRCCS Policlinico San Donato, Metropolitan City of Milan, ITALY
(7) Cedars-Sinai Medical Center, CA, UNITED STATES

+

Lond19A-POS002
Early infections after TAVR: predictors and prognostic value
DE MARZO V. (1), DETTORI S. (1), BUSCAGLIA A. (1), NICOLINI L. A. (1), CANEPA M. (1), BOASI V. (2), BENENATI S. (1), BALBI M. (1), PORTO I. (1)
(1) IRCCS AOU San Martino, Metropolitan City of Genoa ITALY
(2) Sanremo Hospital, Province of Imperia ITALY

+

Lond19A-POS004
The iliofemoral tortuosity score predicts access and bleeding complications during transfemoral TAVI
MACH M. (1), POSCHNER T. (2), WATZAL V. (2), HASAN W. (3), WINKLER B. (2), STROUHAL A. (4), ADLBRECHT C. (4), DELLE-KARTH G. (4), GRABENWöGER M. (2)
(1) Medical University Vienna, Department of Cardiac Surgery, Vienna AUSTRIA
(2) Hospital Hietzing, Department of Cardiothoracic and Vascular Surgery, Vienna AUSTRIA
(3) Imperial College London, London UNITED KINGDOM
(4) Hospital Hietzing, Department of Cardiology, Vienna AUSTRIA

+

Lond19A-POS006
Related factors to high platelet reactivity in patients with severe aortic stenosis undergoing TAVI
JIMENEZ DIAZ V. A. (1), JIMENEZ DIAZ V. A. (2), JIMENEZ V. (2), TELLO-MONTOLIU A. (3), MORENO R. (4), CRUZ GONZALEZ I. (5), ROMAGUERA R. (6), MOLINA NAVARRO E. (7), DE MIGUEL CASTRO A. (2), ORTIZ SAEZ A. (2), FERNANDEZ BARBEIRA S. (2), BASTOS FERNANDEZ G. (2), ESTEVEZ LOUREIRO R. (2)
(1) ,
(2) Hospital Álvaro Cunqueiro, Vigo SPAIN
(3) Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Murcia SPAIN
(4) Hospital La Paz-madrid, Madrid SPAIN
(5) Hospital Clínico Universitario de Salamanca, Salamanca SPAIN
(6) Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat SPAIN
(7) Hospital Virgen de las Nieves, Granada SPAIN

+

Lond19A-POS008
Valvular remodelling and myocyte dysfunction at an early stage of ischaemic mitral regurgitation in a relevant translational pig model
HAMZA O. (1), KISS A. (1), BODI B. (1), PAPP Z. (1), KRAMER A. (1), TILLMANN K. (1), ABRAHAM D. (1), PODESSER B. K. (1)
(1) Medical University of Vienna, Vienna AUSTRIA

+

Lond19A-POS009
Automatic mitral annulus detection and quantification for consistent pre-TMVR planning
LOPES P. (1), WIRIX-SPEETJENS R. (1), SIJBERS J. (2), VANDER SLOTEN J. (3), BOSMANS J. (4), VAN HERCK P. (4)
(1) Materialise HQ, Leuven BELGIUM
(2) Visionlab, Antwerp BELGIUM
(3) KU Leuven - BMe Division - Mechanical Engineering Department, Leuven BELGIUM
(4) University Hospital Antwerp, Edegem BELGIUM

+

Lond19A-POS010
Minimally invasive transradial approach for percutaneous closure of aortic paravalvular leaks: a single-centre experience
ORTEGA-PAZ L. (1), REGUEIRO A. (1), BRUGALETTA S. (1), PERDOMO J. M. (1), SANCHIS L. (1), MASOTTI M. (1), SABATé M. (1), FREIXA X. (1)
(1) Hospital Clínic i Provincial de Barcelona, Barcelona SPAIN

+

Lond19A-POS011
Predictors and clinical outcomes associated with the utilisation of the repositioning mechanism following TAVI with a self-expandable valve
ATTIZZANI G. (1), DALLAN L. (1), YAKUBOV S. (2), MARKOWITZ A. (1), DEEB G. M. (3), REARDON M. (4), HUANG J. (5), POPMA J. (6)
(1) University Hospitals Cleveland Medical Center, OH UNITED STATES
(2) Riverside Methodist- Ohio Health , Columbus UNITED STATES
(3) University of Michigan Hospital, MI UNITED STATES
(4) Methodist Debakey Heart and Vascular Center, TX UNITED STATES
(5) Medtronic Mounds View Office, MN UNITED STATES
(6) Beth Israel Deaconess Medical Center (BIDMC), MA UNITED STATES

+

Loading...